Trending News
News
News
Drais Pharmaceuticals and Diatos Partner to Develop and Commercialize DTS-108 for Treatment of Cancer
DTS-108 is currently ready to begin Phase I clinical trials in Europe for the treatment of patients with advanced or metastatic solid tumors.
News
In Vitro Diagnostics Industry Welcomes Pathology Report
The British In Vitro Diagnostics Association has welcomes the publication of the report of the second phase of Lord Carter’s Independent Review of Pathology Services.
News
nanoTherics Wins R&D Grant from Advantage West Midlands to Further Augment Gene Transfection Product Portfolio
The grant will enable the Company to progress development of additional novel gene transfection technologies to augment its product portfolio.
News
Galapagos and GlaxoSmithKline Expand Osteoarthritis Alliance
Galapagos receives a payment of €2 million cash from GSK for the addition of two new drug targets.
News
Mouse Studies Show Gene Therapy Method Holds Promise in Targeting Tumor Blood Vessels for Destruction
Researchers develop a method for delivering a therapeutic gene to the blood vessels of tumors in mice that damages the blood vessels and disrupts the blood flow to tumors.
News
Researchers Advance Knowledge of Little ‘Nano-Machines’ in Our Body
A discovery by Canada-U.S. biophysicists improves the understanding of ion channels, akin to little ‘nano-machines’ or ‘nano-valves’ in our body.
News
AstraZeneca and MAP Collaborate for Development and Commercialization of Unit Dose Budesonide
Unit Dose Budesonide is being developed as a potential treatment for pediatric asthma and is currently in Phase III clinical development.
News
Baxter Receives EMEA Positive Opinion for CELVAPAN, the First Cell Culture-Based Pandemic Flu Vaccine
Clinical data from a Phase III and subsequent booster study demonstrate safety, immune response and cross-protective memory.
News
Champions Biotechnology Partners to Establish Agreements for Preclinical Evaluation of Oncology Drugs
Champions Biotechnology’s Biomerk Tumorgrafts™ will be utilized by the Centocor for the preclinical evaluation of certain therapeutic agents.
News
Pfizer and Celldex Announce Amendment to ACT III Study of CDX-110 in Glioblastoma Multiforme
The ACT III study will provide a multi-center non-randomized dataset for CDX-110 in patients with newly diagnosed GBM.
Advertisement